Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah M Jones

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|March 10, 2023
Tiered approach to evaluate the CYP3A victim and perpetrator drug-drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labelingDarcy J Mulford, Diane Ramsden, Liming Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 24, 2023
A comprehensive evaluation in clinic and physiologically-based pharmacokinetic modeling and simulation to confirm lack of cytochrome P450-mediated drug-drug interaction potential for pomotrelvirZiping Yang, Nathalie Rioux, Ludwig Vincent, et al.
Behavior Therapy|March 7, 2020
Children's Facial Muscular Movements and Risk for Early Psychopathology: Assessing Clinical UtilityAdam S Grabell, Hannah M Jones, Aimee E Wilett, et al.
Clinical Pharmacology and Therapeutics|June 13, 2020
Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK ModelingKaren Rowland Yeo, Mian Zhang, Xian Pan, et al.
Pharmaceutics|May 27, 2023
Physiologically Based Pharmacokinetic Model Development and Verification for Bioequivalence Testing of Bempedoic Acid Oral Suspension and Reference Tablet FormulationBenny M Amore, Nikunjkumar Patel, Priya Batheja, et al.
JCO Global Oncology|October 5, 2022
Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic ReviewRichard Ward, Hannah M Jones, Davis Witt, et al.
Pediatric Blood & Cancer|September 21, 2022
Cure4Kids: Two decades of knowledge transferDaniel C Moreira, Hannah M Jones, Elizabeth Schaeffer, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 10, 2026
Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions With the Antibody-Drug Conjugate Trastuzumab DeruxtecanAkiko Watanabe, Katherine L Gill, Kuan-Fu Chen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2011
The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearanceKatherine S Fenner, Hannah M Jones, Mohammed Ullah, et al.
European Journal of Clinical Pharmacology|November 15, 2007
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibitionAshok Rakhit, Michael P Pantze, Scott Fettner, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
CPT: Pharmacometrics & Systems Pharmacology|March 10, 2023
Tiered approach to evaluate the CYP3A victim and perpetrator drug-drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labelingDarcy J Mulford, Diane Ramsden, Liming Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 24, 2023
A comprehensive evaluation in clinic and physiologically-based pharmacokinetic modeling and simulation to confirm lack of cytochrome P450-mediated drug-drug interaction potential for pomotrelvirZiping Yang, Nathalie Rioux, Ludwig Vincent, et al.
Behavior Therapy|March 7, 2020
Children's Facial Muscular Movements and Risk for Early Psychopathology: Assessing Clinical UtilityAdam S Grabell, Hannah M Jones, Aimee E Wilett, et al.
Clinical Pharmacology and Therapeutics|June 13, 2020
Impact of Disease on Plasma and Lung Exposure of Chloroquine, Hydroxychloroquine and Azithromycin: Application of PBPK ModelingKaren Rowland Yeo, Mian Zhang, Xian Pan, et al.
Pharmaceutics|May 27, 2023
Physiologically Based Pharmacokinetic Model Development and Verification for Bioequivalence Testing of Bempedoic Acid Oral Suspension and Reference Tablet FormulationBenny M Amore, Nikunjkumar Patel, Priya Batheja, et al.
JCO Global Oncology|October 5, 2022
Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic ReviewRichard Ward, Hannah M Jones, Davis Witt, et al.
Pediatric Blood & Cancer|September 21, 2022
Cure4Kids: Two decades of knowledge transferDaniel C Moreira, Hannah M Jones, Elizabeth Schaeffer, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 10, 2026
Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions With the Antibody-Drug Conjugate Trastuzumab DeruxtecanAkiko Watanabe, Katherine L Gill, Kuan-Fu Chen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2011
The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearanceKatherine S Fenner, Hannah M Jones, Mohammed Ullah, et al.
European Journal of Clinical Pharmacology|November 15, 2007
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibitionAshok Rakhit, Michael P Pantze, Scott Fettner, et al.
Pageof 10